IDXX logo

IDEXX Laboratories Inc. (IDXX)

$566.79

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on IDXX

Market cap

$44.71B

EPS

13.59

P/E ratio

41.4

Price to sales

10

Dividend yield

--

Beta

1.552935

Price on IDXX

Previous close

$563.53

Today's open

$555.96

Day's range

$552.25 - $571.88

52 week range

$504.56 - $769.98

Profile about IDXX

CEO

Jonathan J. Mazelsky

Employees

11000

Headquarters

Westbrook, ME

Exchange

Nasdaq Global Select

Shares outstanding

78882997

Issue type

Common Stock

IDXX industries and sectors

Healthcare

Medical Diagnostics & Screening

News on IDXX

Baron Asset Fund Q1 2026 Contributors, Detractors And Recent Activity

SpaceX is generating significant value with the rapid expansion of its Starlink broadband service. CoStar Group's shares fell due to multiple compression driven by rising fears about the potential impact of AI on the company's business.

news source

Seeking Alpha • Jun 1, 2026

news preview

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

IDEXX Laboratories NASDAQ: IDXX President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company's innovation pipeline, expanding commercial reach and growing use of software and artificial intelligence across veterinary diagnostics.

news source

MarketBeat • May 30, 2026

news preview

IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript

IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript

news source

Seeking Alpha • May 27, 2026

news preview

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX expands Fecal Dx™ antigen testing with taeniid tapeworm detection for broader intestinal parasite screening in wellness and sick-pet care.

news source

Business Wire • May 26, 2026

news preview

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX integrates SDMA into most common Catalyst chemistry profiles, enabling earlier detection of kidney disease through routine in‑clinic testing.

news source

Business Wire • May 19, 2026

news preview

IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 27, 2026 from 10:55 am – 11:25 am (ET). A live audio webcast of the presentation will be available through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the presentation will b.

news source

Business Wire • May 14, 2026

news preview

Idexx Laboratories Raises Guidance On Higher Clinical Visits, Diagnostic Frequency

Idexx Laboratories Inc (NASDAQ:IDXX) shares are up on Tuesday as the company recently announced strong first-quarter results, showcasing a 14% revenue growth.

news source

Benzinga • May 5, 2026

news preview

Idexx Claws Down A Beat As Shares Bound Higher On A Guidance Hike

Idexx stock jumped early Tuesday on better-than-expected first-quarter sales and earnings. The firm raised its 2026 guidance.

news source

Investors Business Daily • May 5, 2026

news preview

IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call Transcript

IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call Transcript

news source

Seeking Alpha • May 5, 2026

news preview

IDEXX Laboratories Announces First Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. First Quarter Results The Company reports revenues of $1,141 million for the first quarter of 2026, an increase of 14% as reported and 11% organic, driven by Companion Animal Group ("CAG") growth of 15% as reported and 12% organic. First quarter earnings per diluted share (“EPS”) were $3.47, an increase of 17% as reported and 15% on a c.

news source

Business Wire • May 5, 2026

news preview

¹ Disclosures

Get started with M1

Invest in IDEXX Laboratories Inc.

Open an M1 investment account to buy and sell IDEXX Laboratories Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in IDXX on M1